 |
 |
|
|
|
RESÚMENES MARZO 2010 |
Schizophrenia-Psychotic
Disorders & Antipsychotics
(Haga un click en la
información del journal
para acceder al resúmen)
5
– doble-ciego o
metanálisis; 4 – subanálisis o estudio
aleatorizado; 3
– revisión, abierto, básico; 2 –
casos; 1 – opinión
GRATIS = Texto
gratuito en algunos países de la región iberoamericana
3! -
Resolution
and remission in schizophrenia: getting well and staying well
David
Yeomans, Mark Taylor, Alan Currie, Richard Whale, Keith Ford, Chris
Fear,
Joanne Hynes, Gary Sullivan, Bruce Moore and Tom Burns
Advances in Psychiatric
Treatment (2010) 16: 86-95
3! - Increased Synaptic
Dopamine Function in Associative Regions of the Striatum in
Schizophrenia
Lawrence S. Kegeles,
Anissa
Abi-Dargham, W. Gordon Frankle, Roberto Gil, Thomas B. Cooper, Mark
Slifstein,
Dah-Ren Hwang, Yiyun Huang, Suzanne N. Haber, Marc Laruelle
Arch Gen
Psychiatry. 2010;67(3):231-239
3 - Prediction of
Psychosis in
Adolescents and Young Adults at High Risk. Results
From the Prospective European
Prediction of Psychosis Study
Stephan Ruhrmann,
Frauke
Schultze-Lutter, Raimo K. R. Salokangas, Markus Heinimaa, Don Linszen,
Peter
Dingemans, Max Birchwood, Paul Patterson, Georg Juckel, Andreas Heinz,
Anthony
Morrison, Shôn Lewis, Heinrich Graf von Reventlow, Joachim
Klosterkötter
Arch Gen
Psychiatry. 2010;67(3):241-251
3!! - Severe Mental
Disorders in
Offspring With 2 Psychiatrically Ill Parents
Irving I. Gottesman,
Thomas
Munk Laursen, Aksel Bertelsen, Preben Bo Mortensen
Arch Gen
Psychiatry. 2010;67(3):252-257
3 -
Prenatal Infection and Schizophrenia: A Review of
Epidemiologic and Translational Studies
Alan
S. Brown, and Elena J.
Derkits
Am J Psychiatry 2010;
167:261-280
4 - Safety and
tolerability of once-daily extended
release quetiapine fumarate in acute schizophrenia: pooled data from
randomised,
double-blind, placebo-controlled studies
Didier Meulien,
Karin Huizar, Martin Brecher
Human
Psychopharmacology: Clinical and Experimental. Volume
25 Issue 2, Pages 103 - 115
4< - Neurocognition and
its influencing factors in the
treatment of schizophrenia - effects of aripiprazole,
olanzapine,
quetiapine and risperidone
M. Riedel, R.
Schennach-Wolff, R. Musil, S. Dehning,
A. Cerovecki, M. Opgen-Rhein, J. Matz, F. Seemüller, M. Obermeier,
R. R. Engel,
N. Müller, H.-J. Möller, I. Spellmann
Human
Psychopharmacology: Clinical and Experimental. Volume
25 Issue 2, Pages 116 - 125
3! - The effect of
dopamine partial agonists on the
nicotine dependency in patients with schizophrenia
Se Hee Kim, Doug
Hyun Han, So Youn Joo, Kyung Joon Min
Human
Psychopharmacology: Clinical and Experimental. Volume
25 Issue 2, Pages 187 - 190
3! - D2
Receptor Genetic Variation and Clinical
Response to Antipsychotic Drug Treatment: A Meta-Analysis
Jian-Ping
Zhang, Todd Lencz, and
Anil K. Malhotra
Am J Psychiatry Published
March 1, 2010
3! - Repetitive
Transcranial
Magnetic Stimulation for Negative Symptoms of Schizophrenia: Review and
Meta-Analysis
Jozarni
J. Dlabač-de Lange, Rikus Knegtering, and André Aleman
J Clin Psychiatry. February
23, 2010
3 - How much more
effective do depot antipsychotics have
to be compared to oral antipsychotics before they are prescribed?
Johannes Hamann,
Rosmarie Mendel,
Stephan Heres, Stefan Leucht and Werner Kissling
European
Neuropsychopharmacology. Volume 20, Issue 4, April 2010, Pages 276-279
GRATIS 3 -
Homeostatic Imbalance of Purine Catabolism in First-Episode
Neuroleptic-Naïve
Patients with Schizophrenia
Yao JK,
Dougherty GG Jr, Reddy RD, Keshavan MS, Montrose DM, et al.
5 - Long-Term Assessment of Asenapine vs.
Olanzapine in Patients with
Schizophrenia or Schizoaffective Disorder
J. Schoemaker,
D. Naber, P. Vrijland,
J. Panagides, R. Emsley
Pharmacopsychiatry. March 2010
3 -
Asenapine induces
differential regional effects on serotonin receptor subtypes
FI
Tarazi,
T. Moran-Gates, EHF Wong, B. Henry, M. Shahid
Journal
of Psychopharmacology, Vol. 24, No. 3, 341-348 (2010)
3 -
Effects of quetiapine,
risperidone, 9-hydroxyrisperidone and ziprasidone on the survival of
human
neuronal and immune cells in vitro
AJ
Schmidt, JC Krieg, HW Clement, UM Hemmeter, E. Schulz, H. Vedder, P.
Heiser
Journal
of Psychopharmacology, Vol. 24, No. 3, 349-354 (2010)
3!! -
Schizophrenia and 1957 Pandemic of Influenza:
Meta-analysis
Jean-Paul
Selten, Aleida Frissen,
Gerty Lensvelt-Mulders and Vera A. Morgan
Schizophrenia Bulletin 2010
36(2):219-228
3 -
Differential Effects of Various Typical and Atypical
Antipsychotics on Plasma Glucose and Insulin Levels in the Mouse:
Evidence for
the Involvement of Sympathetic Regulation
Yvette
E. Savoy, Michael A.
Ashton, Matthew W. Miller, Frank M. Nedza, Douglas K. Spracklin, Mark
H.
Hawthorn, Hans Rollema, F. Fatima Matos and Eva Hajos-Korcsok
Schizophrenia Bulletin 2010
36(2):410-418
GRATIS 3 -
Effectiveness of second-generation antipsychotics: a naturalistic,
randomized comparison of olanzapine, quetiapine, risperidone, and
ziprasidone
Erik
Johnsen,
Rune A Kroken, Tore Wentzel-Larsen
and Hugo
A Jorgensen
3 -
Risperidone and
haloperidol promote survival of stem cells in the rat hippocampus
Gerburg Keilhoff,
Gisela Grecksch, Hans-Gert Bernstein, Thomas Roskoden
and Axel Becker
3 -
Comparing effectiveness of
risperidone with first-generation antipsychotic medications in patients
with
schizophrenia-spectrum disorders
Alvin
Liew, Swapna Verma, Lye Yin Poon, Abdin Edimansyah, Mythily
Subramaniam,
Janhavi Vaingankar, and Siow Ann Chong
J
Psychopharmacol. First published on December 4, 2009
3 -
Effect of aripiprazole,
risperidone, and olanzapine on the acoustic startle response in
Japanese
chronic schizophrenia
Taro Kishi,
Masatsugu Moriwaki, Tsuyoshi Kitajima,
Kunihiro Kawashima,
Tomo Okochi, Yasuhisa Fukuo, Osamu Furukawa,
Hiroshi Naitoh, Kiyoshi Fujita and Nakao Iwata
Psychopharmacology.
Volume 209, Number 2 / April, 2010: 185-190
3 -
Antihistaminergic
antipsychotics cause weight gain
T. Veselinović
und H. Himmerich
Der
Nervenarzt. Volume 81, Number 3 / March, 2010: 329-334
3 - Predictors of
adherence to atypical antipsychotics
(risperidone or olanzapine) in older patients with schizophrenia: an
open study
of 3½ years duration
C. W. Ritchie, S.
Harrigan, M. Mastwyk, S. Macfarlane,
N. Cheesman, D. Ames
International
Journal of Geriatric Psychiatry. Volume 25 Issue
4, Pages 411 - 418
3! - Diagnostic
Characteristics
of Clozapine-Induced Myocarditis Identified by an Analysis of 38 Cases
and 47
Controls
Kathlyn
J. Ronaldson, Andrew J. Taylor, Paul B. Fitzgerald, Duncan J. Topliss,
Maros
Elsik, and John J. McNeil
3 -
Reduced serum BDNF levels
in patients with chronic schizophrenic disorder in relapse, who were
treated
with typical or atypical antipsychotics
Emmanouil
N. Rizos,
Athanasia
Papadopoulou
World Journal of Biological
Psychiatry. March
2010, Vol. 11, No. 2_2, Pages 251-255
3 - Different
patterns of longitudinal changes in plasma
levels of catecholamine metabolites and brain-derived neurotrophic
factor after
administration of atypical antipsychotics in first episode untreated
schizophrenic patients
Reiji
Yoshimura
World Journal of Biological
Psychiatry. March
2010, Vol. 11, No. 2_2, Pages 256-261
3 - The
first- and second-generation antipsychotic drugs
affect ADP-induced platelet aggregation
Anna
Dietrich-Muszalska,
Jolanta
Rabe-Jablonska
World Journal of Biological
Psychiatry. March
2010, Vol. 11, No. 2_2, Pages 268-275
3 -
Inhibitory effects of polyphenol compounds on lipid
peroxidation caused by antipsychotics (haloperidol and amisulpride) in
human
plasma in vitro
Anna
Dietrich-muszalska,
Beata Olas
World Journal of Biological
Psychiatry. March
2010, Vol. 11, No. 2_2, Pages 276-281
3 - The
effects of the second generation antipsychotics
and a typical neuroleptic on collagen-induced platelet aggregation in vitro
Anna Dietrich-Muszalska, Jolanta
Rabe-Jabłońska
World Journal of Biological
Psychiatry. March
2010, Vol. 11, No. 2_2, Pages 293-299
3!! -
Risperidone Maintenance Treatment in Schizophrenia: A
Randomized, Controlled Trial
Chuan-Yue
Wang, Yu-Tao Xiang,
Zhuo-Ji Cai, Yong-Zhen Weng, Qi-Jing Bo, Jing-Ping Zhao, Tie-Qiao Liu,
Gao-Hua
Wang, Shi-Min Weng, Hong-Yan Zhang, Da-Fang Chen, Wai-Kwong Tang, Gabor
S. Ungvari,
and For the Risperidone Maintenance Treatment in Schizophrenia (RMTS)
investigators
Am J Psychiatry Published
March 15, 2010
5 -
Efficacy and Safety of Asenapine in a Placebo- and
Haloperidol-Controlled Trial in Patients With Acute Exacerbation of
Schizophrenia
Kane,
John M; Cohen, Michael; Zhao, Jun; Alphs, Larry; Panagides, John
Journal of Clinical
Psychopharmacology: April 2010 - Volume 30 - Issue 2 - pp 106-115
3! -
Antipsychotic Drug Treatment in First-Episode
Psychosis: Should Patients be Switched to a Different Antipsychotic
Drug After
2, 4, or 6 Weeks of Nonresponse?
Derks,
Eske M; Fleischhacker, W. Wolfgang; Boter, Han; Peuskens, Jozef; Kahn,
Rene S;
for the EUFEST Study Group
Journal of Clinical
Psychopharmacology: April 2010 - Volume 30 - Issue 2 - pp 176-180
3 -
Higher Motor Activity in Schizophrenia Patients
Treated With Olanzapine Versus Risperidone
Walther,
Sebastian; Horn, Helge; Razavi, Nadja; Koschorke, Philipp; Wopfner,
Alexander;
Müller, Thomas J; Strik, Werner
Journal of Clinical
Psychopharmacology: April 2010 - Volume 30 - Issue 2 - pp 181-184
5 - Augmentation With
Citalopram
for Suicidal Ideation in Middle-Aged and Older Outpatients With
Schizophrenia
and Schizoaffective Disorder Who Have Subthreshold Depressive Symptoms:
A
Randomized Controlled Trial
Sidney
Zisook, John W. Kasckow, Nicole M. Lanouette, Shahrokh Golshan, Ian
Fellows,
Ipsit Vahia, Somaia Mohamed, and Sanjai Rao
3 - A
Novel Mechanism and Treatment Target for
Presynaptic Abnormalities in Specific Striatal Regions in Schizophrenia
Vilte
E Barakauskas, Clare L Beasley, Alasdair M Barr, Athena
R Ypsilanti, Hong-Ying Li, Allen E Thornton,
Hubert Wong,
Gorazd Rosokilja, J John Mann, Branislav Mancevski,
Zlatko Jakovski, Natasha Davceva, Boro Ilievski, Andrew
J Dwork, Peter Falkai and William G Honer
Neuropsychopharmacology (2010)
35, 1226–1238
3! - Prevalence of
Negative
Symptoms in Outpatients With Schizophrenia Spectrum Disorders Treated
With
Antipsychotics in Routine Clinical Practice: Findings From the CLAMORS
Study
Julio
Bobes, Celso Arango, Margarida Garcia-Garcia, and Javier Rejas, for the
CLAMORS
Study Collaborative Group
J Clin Psychiatry
2010;71(3):280–286
3! - Cardiovascular
Disease
Mortality in Patients With Chronic Schizophrenia Treated With
Clozapine: A
Retrospective Cohort Study
Deanna
L. Kelly, Robert P. McMahon, Fang Liu, Raymond C. Love, Heidi J.
Wehring,
Joo-Cheol Shim, Kimberly R. Warren, and Robert R. Conley
J Clin Psychiatry
2010;71(3):304-311
5 -
Cholinesterase Inhibitors as Adjunctive Therapy in
Patients with Schizophrenia and Schizoaffective Disorder: A Review and
Meta-Analysis of the Literature
Ribeiz,
Salma R.I; Bassitt, Débora P; Arrais, Jony A; Avila, Renata;
Steffens, David C;
Bottino, Cássio M.C
CNS Drugs: 1 April 2010 - Volume 24 - Issue
4 - pp
303-317
3! - Predictors and
clinical consequences of
non-adherence with antipsychotic medication in the outpatient treatment
of
schizophrenia
Diego Novick, Josep
Maria
Haro, David Suarez, Victor Perez, Ralf W. Dittmann and Peter M. Haddad
Psychiatry Research. Volume 176, Issues 2-3, 30 April 2010,
Pages
109-113
3 -
Changes in weight and body mass index during treatment with melperone,
clozapine and typical neuroleptics
William
V. Bobo, Karuna Jayathilake, Myung A. Lee and Herbert Y. Meltzer
Psychiatry Research. Volume 176, Issues 2-3, 30 April 2010,
Pages
114-119
3 - Neutropenia Induced by Second Generation
Antipsychotics: A Prospective
Investigation
M.
A. Rettenbacher, A. Hofer,
G. Kemmler, W. W. Fleischhacker
Pharmacopsychiatry 2010;
43(2): 41-44
3 - Effect of Aripiprazole on Cognition in the
Treatment of Patients with
Schizophrenia
M. Riedel,
I. Spellmann,
R. Schennach-Wolff, R. Musil, S. Dehning,
A. Cerovecki,
M. Opgen-Rhein, J. Matz, F. Seemüller,
M. Obermeier,
E. Severus, R. R. Engel, N. Müller,
H.-J. Möller
Pharmacopsychiatry 2010;
43(2): 50-57
3 - Prospective, Open Study of Long-Acting
Injected Risperidone versus Oral
Antipsychotics in 88 Chronically Psychotic Patients
P. Girardi,
G. Serafini, M. Pompili, M. Innamorati,
R. Tatarelli, R.
J. Baldessarini
Pharmacopsychiatry 2010;
43(2): 66-72
3< -
Impact of Smoking Cessation on Psychiatric Inpatients
Treated with Clozapine or Olanzapine
Cole,
Miranda L; Trigoboff, Eileen; Demler, Tammie Lee; Opler, Lewis A
Journal of Psychiatric Practice: March 2010
- Volume
16 - Issue 2 - pp 75-81
3! - How Sequential
Studies Inform Drug Development:
Evaluating the Effect of Food Intake on Optimal Bioavailability of
Ziprasidone
Lincoln, Jana; Stewart, Mark E; Preskorn, Sheldon H
Journal of Psychiatric Practice: March 2010
- Volume
16 - Issue 2 - pp 103-114
3 -
Impact of Tobacco Smoking Cessation on Stable
Clozapine or Olanzapine Treatment
The Annals of
Pharmacotherapy: Vol. 44, No. 4, pp. 727-732
3! - Efficacy of
Metformin and
Topiramate in Prevention and Treatment of Second-Generation
Antipsychotic–Induced Weight Gain
Lara K Ellinger,
Heather J
Ipema, and Joan M Stachnik
Ann
Pharmacother 2010;44:668-679
GRATIS 3 -
Effectiveness of second-generation antipsychotics: a naturalistic,
randomized comparison of olanzapine, quetiapine, risperidone, and
ziprasidone
Erik
Johnsen,
Rune A Kroken, Tore Wentzel-Larsen
and Hugo
A Jorgensen
4< - A single-blind,
comparative study of zotepine versus haloperidol
in combination with a mood stabilizer for patients with
moderate-to-severe
mania
Hung-Yu Chan,
Shaw-Hua Jou,
Yeong-Yuh Juang,
Ching-Jui Chang,
Jiahn-Jyh Chen,
Chiung-Hsu Chen,
and
Nan-Ying Chiu
Psychiatry and Clinical Neurosciences. Volume 64 Issue
2, Pages 162 - 169
3 - Repeated effects of
asenapine on adrenergic and cholinergic muscarinic receptors
Yong Kee Choi, Erik
H. F.
Wong, Brian Henry, Mohammed Shahid and Frank I. Tarazi
The
International Journal of Neuropsychopharmacology (2010), 13:405-410
3 - Prolactin
fluctuation over the course of a day during
treatments with three atypical antipsychotics in schizophrenic patients
Norio
Yasui-Furukori, Hanako Furukori, Norio Sugawara,
Shoko Tsuchimine, Akira Fujii, Yoshimasa Inoue, Sunao Kaneko
Human
Psychopharmacology: Clinical and Experimental. Volume 25 Issue
3, Pages 236 - 242
| Regresar a RESÚMENES MARZO 2010 |
©
1999-2010 Jorge M Tamayo, MD, BMSS
Creada en Enero 1999
| Declaración: El contenido de esta página web está basado en las revisiones de la literatura realizadas por el autor y las colaboraciones enviadas por los lectores. Este sitio de Internet está dirijido únicamente a profesionales de la salud en Iberoamérica. Si usted es residente de Estados Unidos de América o Europa, debe tener en cuenta que los contenidos no han sido escogidos con base en información aprobada por la FDA o la EMEA |